TP039/#1520 Phase 1B dose-escalation study of ZN-C3 (wee1 inhibitor) with chemotherapy in patients with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: ZN-C3 plus gemcitabine arm
E-Posters (Trials In Progress)（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要